Latest Insider Transactions at Arvinas, Inc. (ARVN)
This section provides a real-time view of insider transactions for Arvinas, Inc. (ARVN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ARVINAS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ARVINAS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2021
|
Ronald Peck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,011
+37.22%
|
-
|
|
Aug 11
2021
|
Bradley Albert Margus Director |
SELL
Open market or private sale
|
Indirect |
5,000
-11.69%
|
$450,000
$90.03 P/Share
|
|
Aug 02
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
45,922
-1.07%
|
$4,500,356
$98.82 P/Share
|
|
Aug 02
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,922
+4.99%
|
$734,752
$16.0 P/Share
|
|
Jul 28
2021
|
Sean A Cassidy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,242
-9.83%
|
$1,724,200
$100.0 P/Share
|
|
Jul 28
2021
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,242
+8.95%
|
$275,872
$16.0 P/Share
|
|
Jun 30
2021
|
Ronald Peck Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-87.9%
|
$1,520,000
$76.69 P/Share
|
|
Jun 30
2021
|
Ronald Peck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+46.78%
|
$940,000
$47.38 P/Share
|
|
Jun 10
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
43,886
-1.71%
|
$3,554,766
$81.58 P/Share
|
|
Jun 10
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
43,886
+4.79%
|
$702,176
$16.0 P/Share
|
|
Jun 09
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
700
-0.08%
|
$56,000
$80.15 P/Share
|
|
Jun 09
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
700
+0.08%
|
$11,200
$16.0 P/Share
|
|
Apr 05
2021
|
Ian Taylor Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-8.61%
|
$1,650,000
$66.79 P/Share
|
|
Apr 05
2021
|
Ian Taylor Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.43%
|
$400,000
$16.0 P/Share
|
|
Mar 02
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
8,115
-0.97%
|
$624,855
$77.45 P/Share
|
|
Mar 02
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,510
+2.05%
|
-
|
|
Mar 02
2021
|
Sean A Cassidy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,221
-1.38%
|
$171,017
$77.45 P/Share
|
|
Mar 02
2021
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,792
+2.9%
|
-
|
|
Mar 02
2021
|
Ian Taylor Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
894
-1.12%
|
$68,838
$77.45 P/Share
|
|
Mar 02
2021
|
Ian Taylor Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,685
+3.27%
|
-
|
|
Feb 19
2021
|
Ian Taylor Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,456
+7.75%
|
$103,296
$16.0 P/Share
|
|
Feb 17
2021
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
894
+0.29%
|
$14,304
$16.0 P/Share
|
|
Feb 16
2021
|
Ronald Peck Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
20,000
-87.9%
|
$1,540,000
$77.35 P/Share
|
|
Feb 16
2021
|
Ronald Peck Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+46.78%
|
$520,000
$26.58 P/Share
|
|
Feb 16
2021
|
Sean A Cassidy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
41,959
-2.9%
|
$3,272,802
$78.99 P/Share
|
|
Feb 16
2021
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,959
+9.6%
|
$671,344
$16.0 P/Share
|
|
Feb 16
2021
|
John G Houston President and CEO |
SELL
Open market or private sale
|
Direct |
44,000
-1.3%
|
$3,476,000
$79.06 P/Share
|
|
Feb 16
2021
|
John G Houston President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,560
+2.53%
|
$728,960
$16.0 P/Share
|
|
Dec 31
2020
|
John G Houston President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
310
+0.04%
|
$8,990
$29.02 P/Share
|
|
Dec 18
2020
|
Liam Ratcliffe Director |
BUY
Open market or private purchase
|
Indirect |
142,857
+14.79%
|
$9,999,990
$70.0 P/Share
|
|
Nov 09
2020
|
Sean A Cassidy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,006
+1.91%
|
$48,096
$16.0 P/Share
|
|
Nov 09
2020
|
Edward Moore Kennedy Jr. Director |
BUY
Open market or private purchase
|
Direct |
8,333
+16.32%
|
$191,659
$23.99 P/Share
|
|
Oct 14
2020
|
Canaan Ix L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
400,000
-10.03%
|
-
|
|
Jul 20
2020
|
Canaan Ix L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
500,000
-11.14%
|
-
|
|
Jun 30
2020
|
John G Houston President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
315
+0.04%
|
$8,820
$28.5 P/Share
|
|
Jun 10
2019
|
Canaan Ix L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
500,000
-10.02%
|
-
|
|
Oct 01
2018
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+24.16%
|
$16,000,000
$16.0 P/Share
|
|
Oct 01
2018
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
2,138,412
+31.0%
|
-
|
|
Oct 01
2018
|
Canaan Ix L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,989,554
+50.0%
|
-
|
|
Oct 01
2018
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
312,500
+20.21%
|
$5,000,000
$16.0 P/Share
|
|
Oct 01
2018
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
921,234
+50.0%
|
-
|